Release of IL-1β via IL-1β-converting enzyme in a skin dendritic cell line exposed to 2,4-dinitrofluorobenzene

Mediators of Inflammation

Volumn 2005, Issue 3, 2005, Pages 131-138

  Matos, Teresa J ^a   Jaleco, Sara P ^a   Gonçalo, Margarida ^b   Duarte, Carlos B ^a,c   Lopes, M Celeste ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ALLERGEN; BENZYLOXYCARBONYLTYROSYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; COUMARIN DERIVATIVE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; INTERLEUKIN 1BETA RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG; BENZYLOXYCARBONYLTYROSYL VALYL ALANYL ASPARTIC ACID FLUOROMETHYL KETONE; BENZYLOXYCARBONYLTYROSYL-VALYL-ALANYL-ASPARTIC ACID FLUOROMETHYL KETONE; CYSTEINE PROTEINASE INHIBITOR; INTERLEUKIN 1; PEPTIDE CHLOROMETHYL KETONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME SUBSTRATE; FETUS; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN PROCESSING; SKIN; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; CASPASE 1; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; DENDRITIC CELLS; DINITROFLUOROBENZENE; INTERLEUKIN-1; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, INTERLEUKIN-1; SKIN;

EID: 25644454243     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1155/MI.2005.131     Document Type: Article

References (40)

1. Enk AH. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol Med Today. 1997;3(10):423-428.
2. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 1997;9(1):10-16.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-252.
4. Muller G, Knop J, Enk AH. Is cytokine expression responsible for differences between allergens and irritants? Am J Contact Dermat. 1996;7(3):177-184.
5. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 1997;388(6644):782-787.
6. Cumberbatch M, Dearman RJ, Groves RW, Antonopoulos C, Kimber I. Differential regulation of epidermal Langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritantand allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol. 2002;182(2):126-135.
7. Shornick LP, De Togni P, Mariathasan S, et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med. 1996;183(4):1427-1436.
8. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A. 1992;89(4):1398-1402.
9. Aiba S,Manome H, Nakagawa S, et al. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J Invest Dermatol. 2003;120(3):390-399.
10. Brand P, Plochmann S, Valk E, et al. Activation and translocation of p38 mitogen-activated protein kinase after stimulation of monocytes with contact sensitizers. J Invest Dermatol. 2002;119(1):99-106.
11. Pichowski JS, CumberbatchM, Dearman RJ, Basketter DA, Kimber I. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing. J Appl Toxicol. 2001;21(2):115-121.
12. Hazuda D, Webb RL, Simon P, Young P. Purification and characterization of human recombinant precursor interleukin 1 beta. J Biol Chem. 1989;264(3):1689-1693.
13. Mosley B, Urdal DL, Prickett KS, et al. The interleukin-1 receptor binds the human interleukin-1-alpha precursor but not the interleukin-1-beta precursor. J Biol Chem. 1987;262(7):2941-2944.
14. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992;356(6372):768-774.
15. Thornberry NA. The caspase family of cysteine proteases. Br Med Bull. 1997;53(3):478-490.
16. Ariizumi K, Kitajima T, Bergstresser OR, Takashima A. Interleukin-1 beta converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. Eur J Immunol. 1995;25(8):2137-2141.
17. Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM. IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. J Immunol. 2003;170(9):4724-4730.
18. Neumann D, Kollewe C, Martin MU, Boraschi D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J Immunol. 2000;165(6):3350-3357.
19. Girolomoni G, Lutz MB, Pastore S, Assmann CU, Cavani A, Ricciardi-Castagnoli P. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur J Immunol. 1995;25(8):2163-2169.
20. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol. 1993;150(9):3698-3704.
21. Heufler C, Koch F, Schuler G. Granulocyte-macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med. 1988;167(2):700-705.
22. Cruz MT, Duarte CB, Goncalo M, Figueiredo A, Carvalho AP, Lopes MC. Granulocyte-macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line. Immunol Cell Biol. 2001;79(6):590-596.
23. Larregina A, Morelli A, Kolkowski E, Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture. Immunology. 1996;87(2):317-325.
24. Cumberbatch M, Dearman RJ, Kimber I. Characteristics and regulation of the expression on interleukin 1 receptors by murine Langerhans cells and keratinocytes. Arch Dermatol Res. 1998;290(12):688-695.
25. Kampgen E, Koch F, Heufler C, et al. Understanding the dendritic cell lineage through a study of cytokine receptors. J Exp Med. 1994;179(6):1767-1776.
26. Cruz MT, Duarte CB, Goncalo M, Figueiredo A, Carvalho AP, Lopes MC. Differential activation of nuclear factor kappa B subunits in a skin dendritic cell line in response to the strong sensitizer 2,4-dinitrofluorobenzene. Arch Dermatol Res. 2002;294(9):419-425.
27. Cruz MT, Duarte CB, Goncalo M, Figueiredo A, Carvalho AP, Lopes MC. The sensitizer 2,4-dinitrofluorobenzene activates caspase-3 and induces cell death in a skin dendritic cell line. Int J Toxicol. 2003;22(1):43-48.
28. Cruz MT, Goncalo M, Figueiredo A, Carvalho AP, Duarte CB, Lopes MC. Contact sensitizer nickel sulfate activates the transcription factors NF-kB and AP-1 and increases the expression of nitric oxide synthase in a skin dendritic cell line. Exp Dermatol. 2004;13(1):18-26.
29. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol. 1997;27(11):3031-3038.
30. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest. 1997;99(12):3009-3017.
31. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
32. Kahlenberg JM, Dubyak GR. Differing caspase-1 activation states inmonocyte versus macrophage models of IL-1β processing and release. J Leukoc Biol. 2004;76(3):676-684.
33. Mutini C, Falzoni S, Ferrari D, et al.Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol. 1999;163(4):1958-1965.
34. Zepter K, Haffner A, Soohoo LF, et al. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by in-flammatory and immunologic stimuli. J Immunol. 1997;159(12):6203-6208.
35. Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF. Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem. 2001;276(31):28719-28730.
36. HsuHY,WenMH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem. 2002;277(25):22131-22139.
37. Sanz JM, Di Virgilio F. Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J Immunol. 2000;164(9):4893-4898.
38. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol. 2001;166(6):3672-3677.
39. Cumberbatch M, Bhushan M, Dearman RJ, Kimber I, Griffths CE. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol. 2003;132(2):352-359.
40. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol. 2001;166(6):3837-3845.